The Wilf Family Center includes an auditorium, two conference rooms, and a telehealth room that allows communication between patients and medical staff, as well as technology to transmit medical, imaging, and health informatics data from one site to another. State-of-theart conferencing capabilities make this the premier site for knowledge sharing among pediatricians, residents, fellows, and other medical professionals continued on page 2 
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Children's Health 2 as it hosts renowned researchers and innovators in health care.
The auditorium is designed to accommodate patients' medical needs so that hospitalized children and their families can enjoy the space as well. The center will host movie premieres, special performances, and opportunities to meet local celebrities, including members of the Minnesota Vikings and other teams.
Young patients who are unable to leave their rooms can still enjoy the events through an inhospital broadcasting system. "The Wilf Family Center provides an important and accessible way for children and their families to have fun and forget they are in a hospital, which is so important to the healing process," says Carolyn Wilson, R.N., copresident of University of Minnesota Health.
In its 50-year history, the Wilf Family Foundation has donated more than $200 million to various causes.
"Supporting education and health-related causes has been important to our family for several generations," says Mark Wilf, an owner and president of the Minnesota Vikings. "This gift is a wonderful fusion of our commitment to supporting children's health and the chance to see the knowledge and discoveries here shared far beyond the hospital's front doors."
A place for sharing (continued from cover) Photos The newest gift will be used to enhance the hospital experience for children and families and advance research in areas such as neurobehavioral development, rare and infectious diseases, and stem cell therapies. It also will enhance the U's ability to disseminate new knowledge throughout Minnesota. Honor a special person in your life, recognize an inspiring child or parent, or leave a lasting legacy in your name. Your gift of $2,500, payable over five years, will be acknowledged on a lighted tile in a beautiful, permanent installation at University of Minnesota Masonic Children's Hospital. And most important, it will help provide for expert care and the discovery of groundbreaking treatments at one of our country's top-ranked children's hospitals.
To make a gift, visit uofmhope.org or contact Ashley .
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As 3-year-old Kirk Bryan launches into the song "All About That Bass," you can't help but notice his impish grin, his Harry Potter-esque glasses, and the truck-festooned patch covering his left eye.
At 12 weeks old, Kirk was diagnosed with retinoblastoma, a fairly uncommon but treatable pediatric cancer of the retina. Thanks to well-informed parents and innovative treatments at University of Minnesota Masonic Children's Hospital, he's flourishing.
Fortunately for Kirk and his family, treatment regimens for retinoblastoma have changed greatly over the yearsand now have progressively better outcomes, says pediatric ophthalmologist Jill Anderson, M.D., his physician. Kirk's grandmother, for instance, was diagnosed with retinoblastoma at age 2 and had her eye removed.
But not Kirk. Anderson discovered a retina tumor at Kirk's 3-month checkup and gave him laser treatment that very week. Unfortunately, Kirk's eyes developed additional tumors, including one that required leading-edge treatment: intraarterial chemotherapy, also called chemosurgery.
"This used to be a last-resort treatment," says Anderson, explaining that it was used to prevent the need to remove the eye. Gradually, though, surgeons realized that its theoretical risks didn't occur. "It was safer and more effective in some cases," Anderson says.
The procedure begins with an incision in the groin through which a tiny catheter is snaked up through the heart and into the ophthalmic artery. There, the chemotherapy is delivered directly to the eye. And that's why chemosurgery can be far superior to traditional treatments. Systemic chemotherapy can damage healthy cells and cause serious side effects, and radiation can cause disfigurement and increase the child's chance of developing bone cancer later in life.
For one tumor, Kirk received chemosurgery treatment twice from U of M Masonic Children's Hospital radiologist David Nascene, M.D.; for his other four tumors, Anderson provided laser therapy. "Chemosurgery is a really nice option to offer," Anderson says. "In some cases, it's the obvious choice."
It's a choice that wasn't available when Kirk's mother, Anne Bryan, also had the inherited form of retinoblastoma, for which she received cryotherapy and radiation.
Coincidentally, Anne's medical team included pediatric hematologist-oncologist Joseph Neglia, M.D., M.P.H., who now treats her son.
"Bringing Kirk to the U felt like going back home, because there was Joe," says Anne Bryan.
Kirk and his family travel from their Wisconsin home to U of M Masonic Children's Hospital every three months for checkups, and Kirk often wears a patch to ensure that his eyes and brain are working together. The Bryans are thrilled with his progress and hope for even greater advances in retinoblastoma therapies for future patients.
"I would hope that a future treatment is even simpler and more effective," Anne Bryan says. "If people continue to financially support research, it will be." Minnesota Viking John Sullivan will once again host the tournament, which has raised more than $600,000 for University of Minnesota Masonic Children's Hospital since its inception and directly supports the Adopt A Room program.
Visit uofmhope.org for more information.
A recent University of Minnesota study suggests a unique way to prevent the transmission of common but often dangerous viruses through kidney transplantation.
Viral infections are a leading cause of disease and death in patients receiving a kidney transplant. Organ rejection was once the main health concern after a transplant, but with advances in suppressing the immune system, today's patients face a greater risk for serious infections and cancerous cell growth after transplantation. Two common herpes viruses are the most likely culprits: cytomegalovirus (CMV) and EpsteinBarr virus (EBV).
In healthy people, these viruses typically do not cause serious symptoms. But in a person whose immune system is suppressed, such as a person receiving a new kidney, they can be deadly.
The problem arises when a kidney donor carries CMV or EBV and the person receiving the kidney does not. Researchers believe the viruses are transferred through the kidney. Children are at greatest risk because they frequently do not carry either virus.
The U of M study, published in the journal Transplantation and funded by philanthropy, tested whether giving kidney donors an antiviral drug before the transplant would reduce the amount of virus transmitted to the recipient.
The results? No patient receiving a kidney from a donor who took the antiviral medication contracted CMV or EBV after transplantation. In the study's placebo group, one recipient developed CMV, and a second recipient had EBV-related cancer (lymphoma) due to posttransplant lymphoproliferative disorder (PTLD), a serious illness often leading to cancer. Genetic tests on the EBV-related PTLD led the researchers to believe the PTLD was caused by EBV from the donor kidney.
"By preventing the transfer of these common viruses, we want to improve the survival of children receiving kidney transplants and, hopefully, extend the time before a second transplant is needed," says Priya Verghese, M.D., M.P.H., a pediatric nephrologist at University of Minnesota Masonic Children's Hospital who coauthored the study with U colleague and clinical virologist Henry Balfour Jr., M.D. "The implications are significant if we can reduce the number of people on the waiting list for a kidney."
Protecting transplant recipients U study suggests a unique way to prevent infection in kids who receive a new kidney Save the date 7 Nancy Harper, M.D., believes child abuse can go the way of polio and typhoid fever. It's an ambitious vision, but she's knowledgeable, methodical-and optimistic.
The Dartmouth-and Navy-trained Harper isn't just launching a groundbreaking, collaborative approach to identifying child maltreatment across the Twin Cities metro. She's doing it with an eye toward eventually building a statewide program, and prevention is the ultimate goal.
"When we talk about child abuse, let's talk about the fact that child abuse is a toxic stress and just as damaging to a child as a brain injury or cancer." If we don't do a good job of finding these kids and getting them hooked into services, Harper says, the implications for victims-and society-are huge. "We know it has disruptive effects on a child's development, and that it can change everything in terms of their health, potentially even their longevity."
But despite the pervasiveness of abuse and neglect, she adds, it's a winnable fight. 
Partnering for child abuse prevention
At University of Minnesota Masonic Children's Hospital, our pediatric physicians and scientists are icons in their industry. For more than a century, these leaders have pioneered breakthrough research and innovative care that have improved outcomes for children in Minnesota and across the globe.
Guests at WineFest No. 20-A Toast to Children's Health, which will be held May 15 and 16 at the Depot in Minneapolis, will toast two remarkable decades of lifesaving discoveries. Join world-renowned legends of the vine for exceptional wine, gourmet fare, outstanding auctions, and remarkable entertainment during two evenings of festivities.
Cheers to children's heath! Reserve your tickets today at www.thewinefest.org.
Cheers
Friday, May 15 Wine Symposium and Grand Tasting Begin the weekend at the Wine Symposium, led by our iconic honorary winemasters, where guests will taste premier and specialty wines. The spectacular Grand Tasting follows, featuring signature menu selections and more than 400 wines for sampling.
Saturday, May 16 Special Reserve Reception and Fine Wine Dinner
The evening begins with the exclusive Special Reserve Reception, where guests will sample limited-release wines and meet the event's honorary winemasters. All are welcome at the Fine Wine Dinner, emceed by "WCCO This Morning" personalities Jamie Yuccas and Jason DeRusha, which begins with a sparkling wine reception and silent auction and also features a multicourse dinner with premier wine varietals, a live auction, and dancing. 
Presenting sponsor
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University of Minnesota Foundation
The University of Minnesota received a $13 million grant from the National Institutes of Health for the first-ever study of childhood predictors of adult cardiovascular disease. These predictors can include diabetes, abnormal vascular structures, and high blood pressure, among other risk factors.
Study leader Julia Steinberger, M.D., who was recently named head of the U's Division of Pediatric Cardiology, says physicians are seeing more and more children who have these risk factors, which are due "in large part" to the obesity epidemic.
"I've been interested in this topic for 20 years," she says. "Although my training is in congenital heart disease, that actually represents 1 percent of the population. Adult cardiovascular disease is the number one killer of adults."
For the five-year, comprehensive study, five national and two international research partners will look through information from 40,000 pediatric patients examined up to 40 years ago. The partners hope to recruit 23,000 of those people, who are now adults, to participate and find out who among them developed cardiovascular disease.
"The importance of the study is basically to show what has been the holy grail of preventive cardiology," Steinberger says, as now, for the first time, researchers will be able to directly connect risk factors to adult heart disease.
Steinberger hopes the study will both determine preventive measures for young people and generate more questions for future research to answer.
